Nicole MacMillan, Cardiovascular Roundtable
With the recent release of the Society for Cardiovascular Angiography and Interventions’ (SCAI) consensus statement on ad hoc PCI, the discussion around informed consent for cardiac procedures has again risen to the forefront of our members’ topics of interest.
One study we discussed previously suggests that patient education surrounding elective PCI decisions is often infrequent and ripe for improvement. This dialogue with patients will become increasingly critical as providers seek to activate patients in their care to secure both loyalty and engagement throughout the treatment process.
Informed consent for cardiovascular procedures: Resources for your program
Reducing avoidable testing has become a key focus for CV leaders nationwide, yet many have voiced concerns around how patients will perceive physician decisions to forego screenings. Despite these fears, an intriguing study in the most recent Circulation: Cardiovascular Quality and Outcomes suggests that if patients are given the right information and engaged in the decision making process, they are more likely to opt out of avoidable and potentially unnecessary tests.
Increasing patient knowledge, decreasing avoidable testing
A recent study suggests patients pursuing elective PCI are rarely involved in treatment decisions. Comparing candidate patients for coronary artery stenting to patients with prostate cancer, study authors suggest cancer patients are given better education on treatment options, while PCI candidates are infrequently educated on alternatives to PCI despite comparable effectiveness. Given that medication therapy is a viable alternative to elective surgical intervention, candidates for PCI should be given the choice and informed on the pros and cons of each treatment option. Study authors found that patients with prostate cancer considering surgery among other viable interventions are better equipped to determine their own preferences.
Study finds elective PCI decisions lack patient involvement